nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Pyruvic acid—Calcium Acetate—osteoporosis	0.692	1	CrCrCtD
Acetylcysteine—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0401	0.397	CbGbCtD
Acetylcysteine—SLCO1B1—Estradiol—osteoporosis	0.0352	0.348	CbGbCtD
Acetylcysteine—SLC22A6—Conjugated Estrogens—osteoporosis	0.0258	0.255	CbGbCtD
Acetylcysteine—SLC7A11—forelimb zeugopod—osteoporosis	0.00743	0.832	CbGeAlD
Acetylcysteine—Pyruvic acid—PKM—osteoporosis	0.0055	1	CrCbGaD
Acetylcysteine—IKBKB—uterus—osteoporosis	0.000533	0.0597	CbGeAlD
Acetylcysteine—GSS—uterus—osteoporosis	0.000523	0.0586	CbGeAlD
Acetylcysteine—GSS—bone marrow—osteoporosis	0.000444	0.0497	CbGeAlD
Acetylcysteine—Vomiting—Calcium Acetate—osteoporosis	0.000373	0.00348	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Estradiol—osteoporosis	0.00037	0.00346	CcSEcCtD
Acetylcysteine—Pharyngitis—Risedronate—osteoporosis	0.000367	0.00344	CcSEcCtD
Acetylcysteine—Angioedema—Alendronate—osteoporosis	0.000367	0.00343	CcSEcCtD
Acetylcysteine—Angioedema—Ibandronate—osteoporosis	0.000357	0.00334	CcSEcCtD
Acetylcysteine—Cough—Estropipate—osteoporosis	0.000356	0.00333	CcSEcCtD
Acetylcysteine—Syncope—Raloxifene—osteoporosis	0.000354	0.00331	CcSEcCtD
Acetylcysteine—Stomatitis—Zoledronate—osteoporosis	0.000349	0.00326	CcSEcCtD
Acetylcysteine—Nausea—Calcium Acetate—osteoporosis	0.000348	0.00326	CcSEcCtD
Acetylcysteine—Loss of consciousness—Raloxifene—osteoporosis	0.000347	0.00325	CcSEcCtD
Acetylcysteine—Face oedema—Estradiol—osteoporosis	0.000346	0.00323	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000345	0.00322	CcSEcCtD
Acetylcysteine—Cough—Raloxifene—osteoporosis	0.000345	0.00322	CcSEcCtD
Acetylcysteine—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000345	0.00322	CcSEcCtD
Acetylcysteine—Cardiac disorder—Risedronate—osteoporosis	0.000344	0.00321	CcSEcCtD
Acetylcysteine—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.000343	0.00321	CcSEcCtD
Acetylcysteine—Dyspepsia—Etidronic acid—osteoporosis	0.000339	0.00317	CcSEcCtD
Acetylcysteine—Angiopathy—Risedronate—osteoporosis	0.000336	0.00314	CcSEcCtD
Acetylcysteine—Immune system disorder—Risedronate—osteoporosis	0.000334	0.00313	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000334	0.00312	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Risedronate—osteoporosis	0.000334	0.00312	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Estropipate—osteoporosis	0.000333	0.00311	CcSEcCtD
Acetylcysteine—Oedema—Estropipate—osteoporosis	0.000333	0.00311	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000331	0.00309	CcSEcCtD
Acetylcysteine—Flushing—Pamidronate—osteoporosis	0.000327	0.00305	CcSEcCtD
Acetylcysteine—Cardiac disorder—Pamidronate—osteoporosis	0.000327	0.00305	CcSEcCtD
Acetylcysteine—Skin disorder—Estropipate—osteoporosis	0.000323	0.00302	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Estradiol—osteoporosis	0.00032	0.00299	CcSEcCtD
Acetylcysteine—Angiopathy—Pamidronate—osteoporosis	0.000319	0.00299	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Ibandronate—osteoporosis	0.000319	0.00298	CcSEcCtD
Acetylcysteine—Immune system disorder—Pamidronate—osteoporosis	0.000318	0.00297	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Pamidronate—osteoporosis	0.000317	0.00297	CcSEcCtD
Acetylcysteine—Shock—Raloxifene—osteoporosis	0.000317	0.00297	CcSEcCtD
Acetylcysteine—Shock—Ibandronate—osteoporosis	0.000314	0.00294	CcSEcCtD
Acetylcysteine—Skin disorder—Raloxifene—osteoporosis	0.000313	0.00293	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Calcitriol—osteoporosis	0.000312	0.00292	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Raloxifene—osteoporosis	0.000312	0.00291	CcSEcCtD
Acetylcysteine—Skin disorder—Ibandronate—osteoporosis	0.00031	0.0029	CcSEcCtD
Acetylcysteine—Asthma—Estradiol—osteoporosis	0.00031	0.00289	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Ibandronate—osteoporosis	0.000309	0.00289	CcSEcCtD
Acetylcysteine—Nausea—Ergocalciferol—osteoporosis	0.000307	0.00288	CcSEcCtD
Acetylcysteine—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000307	0.00287	CcSEcCtD
Acetylcysteine—Erythema—Pamidronate—osteoporosis	0.000306	0.00287	CcSEcCtD
Acetylcysteine—Urticaria—Etidronic acid—osteoporosis	0.000306	0.00286	CcSEcCtD
Acetylcysteine—Bronchospasm—Estradiol—osteoporosis	0.000304	0.00285	CcSEcCtD
Acetylcysteine—Skin disorder—Calcitriol—osteoporosis	0.000303	0.00284	CcSEcCtD
Acetylcysteine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000302	0.00282	CcSEcCtD
Acetylcysteine—Flushing—Zoledronate—osteoporosis	0.000298	0.00279	CcSEcCtD
Acetylcysteine—Cardiac disorder—Zoledronate—osteoporosis	0.000298	0.00279	CcSEcCtD
Acetylcysteine—Somnolence—Estropipate—osteoporosis	0.000296	0.00277	CcSEcCtD
Acetylcysteine—Angioedema—Risedronate—osteoporosis	0.000294	0.00275	CcSEcCtD
Acetylcysteine—Dyspepsia—Estropipate—osteoporosis	0.000293	0.00274	CcSEcCtD
Acetylcysteine—Angiopathy—Zoledronate—osteoporosis	0.000292	0.00273	CcSEcCtD
Acetylcysteine—Immune system disorder—Zoledronate—osteoporosis	0.00029	0.00272	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Zoledronate—osteoporosis	0.00029	0.00271	CcSEcCtD
Acetylcysteine—Syncope—Risedronate—osteoporosis	0.000289	0.0027	CcSEcCtD
Acetylcysteine—Dyspepsia—Alendronate—osteoporosis	0.000289	0.0027	CcSEcCtD
Acetylcysteine—Cough—Ethinyl Estradiol—osteoporosis	0.000288	0.0027	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Estropipate—osteoporosis	0.000287	0.00269	CcSEcCtD
Acetylcysteine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000287	0.00269	CcSEcCtD
Acetylcysteine—Dyspepsia—Raloxifene—osteoporosis	0.000284	0.00265	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etidronic acid—osteoporosis	0.000283	0.00265	CcSEcCtD
Acetylcysteine—Loss of consciousness—Risedronate—osteoporosis	0.000283	0.00265	CcSEcCtD
Acetylcysteine—Cough—Risedronate—osteoporosis	0.000281	0.00263	CcSEcCtD
Acetylcysteine—Dyspepsia—Ibandronate—osteoporosis	0.000281	0.00263	CcSEcCtD
Acetylcysteine—Angiopathy—Conjugated Estrogens—osteoporosis	0.000281	0.00263	CcSEcCtD
Acetylcysteine—Angioedema—Pamidronate—osteoporosis	0.00028	0.00262	CcSEcCtD
Acetylcysteine—Erythema—Zoledronate—osteoporosis	0.00028	0.00262	CcSEcCtD
Acetylcysteine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00028	0.00261	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000279	0.00261	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000279	0.00261	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000278	0.0026	CcSEcCtD
Acetylcysteine—Somnolence—Calcitriol—osteoporosis	0.000278	0.0026	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000276	0.00258	CcSEcCtD
Acetylcysteine—Syncope—Pamidronate—osteoporosis	0.000275	0.00257	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000272	0.00255	CcSEcCtD
Acetylcysteine—Pruritus—Etidronic acid—osteoporosis	0.000272	0.00255	CcSEcCtD
Acetylcysteine—Oedema—Ethinyl Estradiol—osteoporosis	0.00027	0.00252	CcSEcCtD
Acetylcysteine—Erythema—Conjugated Estrogens—osteoporosis	0.000269	0.00252	CcSEcCtD
Acetylcysteine—Loss of consciousness—Pamidronate—osteoporosis	0.000269	0.00252	CcSEcCtD
Acetylcysteine—Cough—Pamidronate—osteoporosis	0.000267	0.0025	CcSEcCtD
Acetylcysteine—Urticaria—Estropipate—osteoporosis	0.000264	0.00247	CcSEcCtD
Acetylcysteine—Body temperature increased—Estropipate—osteoporosis	0.000263	0.00246	CcSEcCtD
Acetylcysteine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000262	0.00245	CcSEcCtD
Acetylcysteine—Urticaria—Alendronate—osteoporosis	0.00026	0.00244	CcSEcCtD
Acetylcysteine—Body temperature increased—Alendronate—osteoporosis	0.000259	0.00242	CcSEcCtD
Acetylcysteine—Shock—Risedronate—osteoporosis	0.000259	0.00242	CcSEcCtD
Acetylcysteine—Angioedema—Zoledronate—osteoporosis	0.000256	0.00239	CcSEcCtD
Acetylcysteine—Skin disorder—Risedronate—osteoporosis	0.000255	0.00239	CcSEcCtD
Acetylcysteine—Body temperature increased—Raloxifene—osteoporosis	0.000255	0.00238	CcSEcCtD
Acetylcysteine—Urticaria—Ibandronate—osteoporosis	0.000254	0.00237	CcSEcCtD
Acetylcysteine—Body temperature increased—Ibandronate—osteoporosis	0.000252	0.00236	CcSEcCtD
Acetylcysteine—Syncope—Zoledronate—osteoporosis	0.000251	0.00235	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Pamidronate—osteoporosis	0.00025	0.00234	CcSEcCtD
Acetylcysteine—Oedema—Pamidronate—osteoporosis	0.00025	0.00234	CcSEcCtD
Acetylcysteine—Urticaria—Calcitriol—osteoporosis	0.000248	0.00232	CcSEcCtD
Acetylcysteine—Body temperature increased—Calcitriol—osteoporosis	0.000247	0.00231	CcSEcCtD
Acetylcysteine—Angioedema—Conjugated Estrogens—osteoporosis	0.000246	0.0023	CcSEcCtD
Acetylcysteine—Shock—Pamidronate—osteoporosis	0.000246	0.0023	CcSEcCtD
Acetylcysteine—Loss of consciousness—Zoledronate—osteoporosis	0.000246	0.0023	CcSEcCtD
Acetylcysteine—Pharyngitis—Estradiol—osteoporosis	0.000246	0.0023	CcSEcCtD
Acetylcysteine—Hypersensitivity—Estropipate—osteoporosis	0.000245	0.00229	CcSEcCtD
Acetylcysteine—Vomiting—Etidronic acid—osteoporosis	0.000245	0.00229	CcSEcCtD
Acetylcysteine—Cough—Zoledronate—osteoporosis	0.000244	0.00228	CcSEcCtD
Acetylcysteine—Tachycardia—Pamidronate—osteoporosis	0.000244	0.00228	CcSEcCtD
Acetylcysteine—Rash—Etidronic acid—osteoporosis	0.000243	0.00227	CcSEcCtD
Acetylcysteine—Dermatitis—Etidronic acid—osteoporosis	0.000242	0.00227	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Pamidronate—osteoporosis	0.000242	0.00226	CcSEcCtD
Acetylcysteine—Syncope—Conjugated Estrogens—osteoporosis	0.000242	0.00226	CcSEcCtD
Acetylcysteine—Hypersensitivity—Alendronate—osteoporosis	0.000242	0.00226	CcSEcCtD
Acetylcysteine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000237	0.00221	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000237	0.00221	CcSEcCtD
Acetylcysteine—Pruritus—Estropipate—osteoporosis	0.000235	0.0022	CcSEcCtD
Acetylcysteine—Hypersensitivity—Ibandronate—osteoporosis	0.000235	0.0022	CcSEcCtD
Acetylcysteine—Cough—Conjugated Estrogens—osteoporosis	0.000235	0.0022	CcSEcCtD
Acetylcysteine—Dyspnoea—Risedronate—osteoporosis	0.000234	0.00219	CcSEcCtD
Acetylcysteine—Hypotension—Pamidronate—osteoporosis	0.000234	0.00218	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000233	0.00218	CcSEcCtD
Acetylcysteine—Pruritus—Alendronate—osteoporosis	0.000232	0.00217	CcSEcCtD
Acetylcysteine—Dyspepsia—Risedronate—osteoporosis	0.000232	0.00217	CcSEcCtD
Acetylcysteine—Hypersensitivity—Calcitriol—osteoporosis	0.00023	0.00215	CcSEcCtD
Acetylcysteine—Flushing—Estradiol—osteoporosis	0.00023	0.00215	CcSEcCtD
Acetylcysteine—Cardiac disorder—Estradiol—osteoporosis	0.00023	0.00215	CcSEcCtD
Acetylcysteine—Nausea—Etidronic acid—osteoporosis	0.000229	0.00214	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Zoledronate—osteoporosis	0.000228	0.00214	CcSEcCtD
Acetylcysteine—Oedema—Zoledronate—osteoporosis	0.000228	0.00214	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000228	0.00213	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000227	0.00212	CcSEcCtD
Acetylcysteine—Pruritus—Ibandronate—osteoporosis	0.000226	0.00211	CcSEcCtD
Acetylcysteine—Angiopathy—Estradiol—osteoporosis	0.000225	0.0021	CcSEcCtD
Acetylcysteine—Shock—Zoledronate—osteoporosis	0.000225	0.0021	CcSEcCtD
Acetylcysteine—Immune system disorder—Estradiol—osteoporosis	0.000224	0.00209	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Estradiol—osteoporosis	0.000223	0.00209	CcSEcCtD
Acetylcysteine—Dyspnoea—Pamidronate—osteoporosis	0.000223	0.00208	CcSEcCtD
Acetylcysteine—Tachycardia—Zoledronate—osteoporosis	0.000223	0.00208	CcSEcCtD
Acetylcysteine—Somnolence—Pamidronate—osteoporosis	0.000222	0.00208	CcSEcCtD
Acetylcysteine—Skin disorder—Zoledronate—osteoporosis	0.000222	0.00207	CcSEcCtD
Acetylcysteine—Pruritus—Calcitriol—osteoporosis	0.000221	0.00207	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Zoledronate—osteoporosis	0.000221	0.00206	CcSEcCtD
Acetylcysteine—Dyspepsia—Pamidronate—osteoporosis	0.00022	0.00206	CcSEcCtD
Acetylcysteine—Dizziness—Estropipate—osteoporosis	0.00022	0.00206	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00022	0.00206	CcSEcCtD
Acetylcysteine—Oedema—Conjugated Estrogens—osteoporosis	0.00022	0.00206	CcSEcCtD
Acetylcysteine—Dizziness—Alendronate—osteoporosis	0.000217	0.00203	CcSEcCtD
Acetylcysteine—Shock—Conjugated Estrogens—osteoporosis	0.000216	0.00202	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000216	0.00202	CcSEcCtD
Acetylcysteine—Erythema—Estradiol—osteoporosis	0.000216	0.00202	CcSEcCtD
Acetylcysteine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000215	0.00201	CcSEcCtD
Acetylcysteine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000214	0.002	CcSEcCtD
Acetylcysteine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000214	0.002	CcSEcCtD
Acetylcysteine—Hypotension—Zoledronate—osteoporosis	0.000213	0.002	CcSEcCtD
Acetylcysteine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000213	0.00199	CcSEcCtD
Acetylcysteine—Dizziness—Raloxifene—osteoporosis	0.000213	0.00199	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000213	0.00199	CcSEcCtD
Acetylcysteine—Vomiting—Estropipate—osteoporosis	0.000212	0.00198	CcSEcCtD
Acetylcysteine—Dizziness—Ibandronate—osteoporosis	0.000211	0.00197	CcSEcCtD
Acetylcysteine—Rash—Estropipate—osteoporosis	0.00021	0.00196	CcSEcCtD
Acetylcysteine—Dermatitis—Estropipate—osteoporosis	0.00021	0.00196	CcSEcCtD
Acetylcysteine—Urticaria—Risedronate—osteoporosis	0.000209	0.00195	CcSEcCtD
Acetylcysteine—Vomiting—Alendronate—osteoporosis	0.000208	0.00195	CcSEcCtD
Acetylcysteine—Body temperature increased—Risedronate—osteoporosis	0.000208	0.00194	CcSEcCtD
Acetylcysteine—Rash—Alendronate—osteoporosis	0.000207	0.00193	CcSEcCtD
Acetylcysteine—Dermatitis—Alendronate—osteoporosis	0.000206	0.00193	CcSEcCtD
Acetylcysteine—Hypotension—Conjugated Estrogens—osteoporosis	0.000205	0.00192	CcSEcCtD
Acetylcysteine—Vomiting—Raloxifene—osteoporosis	0.000205	0.00192	CcSEcCtD
Acetylcysteine—Dyspnoea—Zoledronate—osteoporosis	0.000204	0.0019	CcSEcCtD
Acetylcysteine—Rash—Raloxifene—osteoporosis	0.000203	0.0019	CcSEcCtD
Acetylcysteine—Dermatitis—Raloxifene—osteoporosis	0.000203	0.0019	CcSEcCtD
Acetylcysteine—Somnolence—Zoledronate—osteoporosis	0.000203	0.0019	CcSEcCtD
Acetylcysteine—Vomiting—Ibandronate—osteoporosis	0.000203	0.0019	CcSEcCtD
Acetylcysteine—Rash—Ibandronate—osteoporosis	0.000201	0.00188	CcSEcCtD
Acetylcysteine—Dermatitis—Ibandronate—osteoporosis	0.000201	0.00188	CcSEcCtD
Acetylcysteine—Dyspepsia—Zoledronate—osteoporosis	0.000201	0.00188	CcSEcCtD
Acetylcysteine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000199	0.00186	CcSEcCtD
Acetylcysteine—Vomiting—Calcitriol—osteoporosis	0.000199	0.00186	CcSEcCtD
Acetylcysteine—Nausea—Estropipate—osteoporosis	0.000198	0.00185	CcSEcCtD
Acetylcysteine—Body temperature increased—Pamidronate—osteoporosis	0.000198	0.00185	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000197	0.00184	CcSEcCtD
Acetylcysteine—Angioedema—Estradiol—osteoporosis	0.000197	0.00184	CcSEcCtD
Acetylcysteine—Rash—Calcitriol—osteoporosis	0.000197	0.00184	CcSEcCtD
Acetylcysteine—Dermatitis—Calcitriol—osteoporosis	0.000197	0.00184	CcSEcCtD
Acetylcysteine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000196	0.00183	CcSEcCtD
Acetylcysteine—Somnolence—Conjugated Estrogens—osteoporosis	0.000196	0.00183	CcSEcCtD
Acetylcysteine—Nausea—Alendronate—osteoporosis	0.000195	0.00182	CcSEcCtD
Acetylcysteine—Hypersensitivity—Risedronate—osteoporosis	0.000194	0.00181	CcSEcCtD
Acetylcysteine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000194	0.00181	CcSEcCtD
Acetylcysteine—Syncope—Estradiol—osteoporosis	0.000193	0.00181	CcSEcCtD
Acetylcysteine—Nausea—Raloxifene—osteoporosis	0.000191	0.00179	CcSEcCtD
Acetylcysteine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000191	0.00178	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00019	0.00178	CcSEcCtD
Acetylcysteine—Nausea—Ibandronate—osteoporosis	0.00019	0.00177	CcSEcCtD
Acetylcysteine—Loss of consciousness—Estradiol—osteoporosis	0.00019	0.00177	CcSEcCtD
Acetylcysteine—Cough—Estradiol—osteoporosis	0.000188	0.00176	CcSEcCtD
Acetylcysteine—Pruritus—Risedronate—osteoporosis	0.000186	0.00174	CcSEcCtD
Acetylcysteine—Nausea—Calcitriol—osteoporosis	0.000186	0.00174	CcSEcCtD
Acetylcysteine—Hypersensitivity—Pamidronate—osteoporosis	0.000184	0.00172	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000182	0.00171	CcSEcCtD
Acetylcysteine—Urticaria—Zoledronate—osteoporosis	0.000181	0.0017	CcSEcCtD
Acetylcysteine—Body temperature increased—Zoledronate—osteoporosis	0.000181	0.00169	CcSEcCtD
Acetylcysteine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000178	0.00167	CcSEcCtD
Acetylcysteine—Pruritus—Pamidronate—osteoporosis	0.000177	0.00165	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Estradiol—osteoporosis	0.000176	0.00165	CcSEcCtD
Acetylcysteine—Oedema—Estradiol—osteoporosis	0.000176	0.00165	CcSEcCtD
Acetylcysteine—Urticaria—Conjugated Estrogens—osteoporosis	0.000175	0.00163	CcSEcCtD
Acetylcysteine—Dizziness—Risedronate—osteoporosis	0.000174	0.00163	CcSEcCtD
Acetylcysteine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000174	0.00163	CcSEcCtD
Acetylcysteine—Shock—Estradiol—osteoporosis	0.000173	0.00162	CcSEcCtD
Acetylcysteine—Tachycardia—Estradiol—osteoporosis	0.000172	0.00161	CcSEcCtD
Acetylcysteine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000172	0.0016	CcSEcCtD
Acetylcysteine—Skin disorder—Estradiol—osteoporosis	0.000171	0.0016	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Estradiol—osteoporosis	0.00017	0.00159	CcSEcCtD
Acetylcysteine—Rash—Ethinyl Estradiol—osteoporosis	0.00017	0.00159	CcSEcCtD
Acetylcysteine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00017	0.00159	CcSEcCtD
Acetylcysteine—Hypersensitivity—Zoledronate—osteoporosis	0.000168	0.00157	CcSEcCtD
Acetylcysteine—Vomiting—Risedronate—osteoporosis	0.000167	0.00156	CcSEcCtD
Acetylcysteine—Rash—Risedronate—osteoporosis	0.000166	0.00155	CcSEcCtD
Acetylcysteine—Dermatitis—Risedronate—osteoporosis	0.000166	0.00155	CcSEcCtD
Acetylcysteine—Dizziness—Pamidronate—osteoporosis	0.000165	0.00155	CcSEcCtD
Acetylcysteine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000162	0.00152	CcSEcCtD
Acetylcysteine—Pruritus—Zoledronate—osteoporosis	0.000162	0.00151	CcSEcCtD
Acetylcysteine—Nausea—Ethinyl Estradiol—osteoporosis	0.00016	0.0015	CcSEcCtD
Acetylcysteine—Vomiting—Pamidronate—osteoporosis	0.000159	0.00149	CcSEcCtD
Acetylcysteine—Rash—Pamidronate—osteoporosis	0.000158	0.00147	CcSEcCtD
Acetylcysteine—Dermatitis—Pamidronate—osteoporosis	0.000158	0.00147	CcSEcCtD
Acetylcysteine—Dyspnoea—Estradiol—osteoporosis	0.000157	0.00147	CcSEcCtD
Acetylcysteine—Somnolence—Estradiol—osteoporosis	0.000156	0.00146	CcSEcCtD
Acetylcysteine—Nausea—Risedronate—osteoporosis	0.000156	0.00146	CcSEcCtD
Acetylcysteine—Pruritus—Conjugated Estrogens—osteoporosis	0.000156	0.00146	CcSEcCtD
Acetylcysteine—Dyspepsia—Estradiol—osteoporosis	0.000155	0.00145	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000152	0.00142	CcSEcCtD
Acetylcysteine—Dizziness—Zoledronate—osteoporosis	0.000151	0.00141	CcSEcCtD
Acetylcysteine—Nausea—Pamidronate—osteoporosis	0.000149	0.00139	CcSEcCtD
Acetylcysteine—Dizziness—Conjugated Estrogens—osteoporosis	0.000145	0.00136	CcSEcCtD
Acetylcysteine—Vomiting—Zoledronate—osteoporosis	0.000145	0.00136	CcSEcCtD
Acetylcysteine—Rash—Zoledronate—osteoporosis	0.000144	0.00135	CcSEcCtD
Acetylcysteine—Dermatitis—Zoledronate—osteoporosis	0.000144	0.00135	CcSEcCtD
Acetylcysteine—Vomiting—Conjugated Estrogens—osteoporosis	0.00014	0.00131	CcSEcCtD
Acetylcysteine—Urticaria—Estradiol—osteoporosis	0.00014	0.00131	CcSEcCtD
Acetylcysteine—Body temperature increased—Estradiol—osteoporosis	0.000139	0.0013	CcSEcCtD
Acetylcysteine—Rash—Conjugated Estrogens—osteoporosis	0.000139	0.0013	CcSEcCtD
Acetylcysteine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000139	0.0013	CcSEcCtD
Acetylcysteine—Nausea—Zoledronate—osteoporosis	0.000136	0.00127	CcSEcCtD
Acetylcysteine—Nausea—Conjugated Estrogens—osteoporosis	0.000131	0.00122	CcSEcCtD
Acetylcysteine—Hypersensitivity—Estradiol—osteoporosis	0.00013	0.00121	CcSEcCtD
Acetylcysteine—Pruritus—Estradiol—osteoporosis	0.000125	0.00116	CcSEcCtD
Acetylcysteine—Dizziness—Estradiol—osteoporosis	0.000116	0.00109	CcSEcCtD
Acetylcysteine—Vomiting—Estradiol—osteoporosis	0.000112	0.00105	CcSEcCtD
Acetylcysteine—Rash—Estradiol—osteoporosis	0.000111	0.00104	CcSEcCtD
Acetylcysteine—Dermatitis—Estradiol—osteoporosis	0.000111	0.00104	CcSEcCtD
Acetylcysteine—Nausea—Estradiol—osteoporosis	0.000105	0.000978	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—LEP—osteoporosis	3.87e-05	0.00045	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IRS2—osteoporosis	3.82e-05	0.000444	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL6—osteoporosis	3.81e-05	0.000444	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RPL24—osteoporosis	3.79e-05	0.000442	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—LTF—osteoporosis	3.79e-05	0.000442	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—LEP—osteoporosis	3.77e-05	0.000439	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IRS2—osteoporosis	3.75e-05	0.000437	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—IL6—osteoporosis	3.74e-05	0.000436	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	3.74e-05	0.000436	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SOST—osteoporosis	3.74e-05	0.000435	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTH1R—osteoporosis	3.73e-05	0.000434	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CALCR—osteoporosis	3.73e-05	0.000434	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoporosis	3.68e-05	0.000429	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IRS1—osteoporosis	3.67e-05	0.000428	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL6—osteoporosis	3.63e-05	0.000423	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—osteoporosis	3.62e-05	0.000421	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IRS1—osteoporosis	3.61e-05	0.000421	CbGpPWpGaD
Acetylcysteine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoporosis	3.58e-05	0.000417	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ATIC—osteoporosis	3.58e-05	0.000417	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PNP—osteoporosis	3.58e-05	0.000417	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—IL1B—osteoporosis	3.58e-05	0.000417	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ACTG1—osteoporosis	3.56e-05	0.000415	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PSMA2—osteoporosis	3.54e-05	0.000413	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PSMA5—osteoporosis	3.54e-05	0.000413	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88-independent cascade—IL6—osteoporosis	3.53e-05	0.000411	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRAK3—osteoporosis	3.53e-05	0.000411	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—osteoporosis	3.52e-05	0.00041	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL6—osteoporosis	3.46e-05	0.000403	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6R—osteoporosis	3.45e-05	0.000402	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	3.45e-05	0.000402	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KL—osteoporosis	3.44e-05	0.000401	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—IL6—osteoporosis	3.4e-05	0.000396	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	3.4e-05	0.000396	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6R—osteoporosis	3.39e-05	0.000395	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CALCR—osteoporosis	3.38e-05	0.000394	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTH1R—osteoporosis	3.38e-05	0.000394	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—MYC—osteoporosis	3.35e-05	0.00039	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ADCY5—osteoporosis	3.35e-05	0.00039	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoporosis	3.34e-05	0.000389	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—GPX1—osteoporosis	3.34e-05	0.000389	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	3.34e-05	0.000389	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IRS1—osteoporosis	3.33e-05	0.000388	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KL—osteoporosis	3.31e-05	0.000385	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL6—osteoporosis	3.29e-05	0.000384	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ACP5—osteoporosis	3.29e-05	0.000383	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IRS1—osteoporosis	3.27e-05	0.000381	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6R—osteoporosis	3.24e-05	0.000377	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ACTG1—osteoporosis	3.23e-05	0.000376	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88-independent cascade—IL6—osteoporosis	3.2e-05	0.000373	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—IL6—osteoporosis	3.18e-05	0.00037	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6R—osteoporosis	3.16e-05	0.000368	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6R—osteoporosis	3.13e-05	0.000364	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	3.13e-05	0.000364	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KL—osteoporosis	3.12e-05	0.000364	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—MTHFR—osteoporosis	3.08e-05	0.000359	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6R—osteoporosis	3.08e-05	0.000358	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TPI1—osteoporosis	3.06e-05	0.000356	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CA2—osteoporosis	3.05e-05	0.000355	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—OXCT1—osteoporosis	3.05e-05	0.000355	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	3.02e-05	0.000352	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KL—osteoporosis	3e-05	0.000349	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoporosis	2.99e-05	0.000348	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL6—osteoporosis	2.99e-05	0.000348	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RAP1A—osteoporosis	2.97e-05	0.000347	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MGLL—osteoporosis	2.97e-05	0.000346	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MGLL—osteoporosis	2.96e-05	0.000345	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTSK—osteoporosis	2.95e-05	0.000344	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NFATC1—osteoporosis	2.9e-05	0.000338	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LRP5—osteoporosis	2.89e-05	0.000337	CbGpPWpGaD
Acetylcysteine—IKBKB—Activated TLR4 signalling—IL6—osteoporosis	2.88e-05	0.000336	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—P4HB—osteoporosis	2.87e-05	0.000335	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—GAPDH—osteoporosis	2.82e-05	0.000329	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.8e-05	0.000326	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—MYC—osteoporosis	2.79e-05	0.000325	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TGFB1—osteoporosis	2.78e-05	0.000324	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.78e-05	0.000323	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.77e-05	0.000323	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LRP6—osteoporosis	2.76e-05	0.000322	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TGFB1—osteoporosis	2.72e-05	0.000317	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoporosis	2.71e-05	0.000316	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AGER—osteoporosis	2.71e-05	0.000315	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RAP1A—osteoporosis	2.7e-05	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—ADCY5—osteoporosis	2.7e-05	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	2.69e-05	0.000314	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MGLL—osteoporosis	2.68e-05	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NFATC1—osteoporosis	2.68e-05	0.000312	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTSK—osteoporosis	2.67e-05	0.000312	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—IL6—osteoporosis	2.66e-05	0.00031	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—IL6—osteoporosis	2.66e-05	0.00031	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—DKK1—osteoporosis	2.66e-05	0.00031	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NFATC1—osteoporosis	2.63e-05	0.000307	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1B—osteoporosis	2.63e-05	0.000306	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LRP5—osteoporosis	2.62e-05	0.000305	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—osteoporosis	2.6e-05	0.000303	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.59e-05	0.000301	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—WNT1—osteoporosis	2.56e-05	0.000298	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—IL6—osteoporosis	2.55e-05	0.000297	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—IDH2—osteoporosis	2.52e-05	0.000294	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—IL6—osteoporosis	2.51e-05	0.000292	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LRP6—osteoporosis	2.51e-05	0.000292	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGA—osteoporosis	2.49e-05	0.00029	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—POMC—osteoporosis	2.46e-05	0.000287	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AGER—osteoporosis	2.45e-05	0.000286	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ADCY5—osteoporosis	2.45e-05	0.000285	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	2.44e-05	0.000284	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—IL6—osteoporosis	2.41e-05	0.000281	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—IL6—osteoporosis	2.39e-05	0.000279	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.39e-05	0.000278	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—IL6—osteoporosis	2.38e-05	0.000277	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1B—osteoporosis	2.38e-05	0.000277	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP27A1—osteoporosis	2.37e-05	0.000276	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—IL6—osteoporosis	2.37e-05	0.000276	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PSMA2—osteoporosis	2.37e-05	0.000276	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PSMA5—osteoporosis	2.37e-05	0.000276	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IRS2—osteoporosis	2.36e-05	0.000275	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—IL6—osteoporosis	2.36e-05	0.000275	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TLN1—osteoporosis	2.33e-05	0.000272	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ACP5—osteoporosis	2.31e-05	0.000269	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.28e-05	0.000266	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—IRS2—osteoporosis	2.27e-05	0.000264	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ENO1—osteoporosis	2.22e-05	0.000259	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—IL6—osteoporosis	2.22e-05	0.000258	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	2.22e-05	0.000258	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—IL6—osteoporosis	2.22e-05	0.000258	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—IL6—osteoporosis	2.2e-05	0.000256	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PSMA2—osteoporosis	2.19e-05	0.000255	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PSMA5—osteoporosis	2.19e-05	0.000255	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—IL6—osteoporosis	2.18e-05	0.000254	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.18e-05	0.000253	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—IL6—osteoporosis	2.17e-05	0.000253	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PSMA2—osteoporosis	2.15e-05	0.00025	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PSMA5—osteoporosis	2.15e-05	0.00025	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TPI1—osteoporosis	2.15e-05	0.00025	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IRS2—osteoporosis	2.14e-05	0.000249	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TLN1—osteoporosis	2.12e-05	0.000246	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IRS1—osteoporosis	2.06e-05	0.00024	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—IRS2—osteoporosis	2.05e-05	0.000239	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CALCA—osteoporosis	2.04e-05	0.000238	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—IL6—osteoporosis	2.02e-05	0.000236	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—P4HB—osteoporosis	2.02e-05	0.000235	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—P4HB—osteoporosis	2.01e-05	0.000234	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	2.01e-05	0.000234	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KL—osteoporosis	2.01e-05	0.000234	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GAPDH—osteoporosis	1.98e-05	0.000231	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—IRS1—osteoporosis	1.98e-05	0.00023	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—IL6—osteoporosis	1.97e-05	0.00023	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	1.96e-05	0.000229	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTH—osteoporosis	1.96e-05	0.000228	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6R—osteoporosis	1.94e-05	0.000225	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—RAP1A—osteoporosis	1.93e-05	0.000225	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RAP1A—osteoporosis	1.92e-05	0.000224	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TGFB1—osteoporosis	1.91e-05	0.000223	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CNR2—osteoporosis	1.91e-05	0.000222	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFATC1—osteoporosis	1.88e-05	0.000219	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IRS1—osteoporosis	1.87e-05	0.000218	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TGFB1—osteoporosis	1.87e-05	0.000217	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—DKK1—osteoporosis	1.86e-05	0.000217	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KL—osteoporosis	1.85e-05	0.000216	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—P4HB—osteoporosis	1.82e-05	0.000213	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KL—osteoporosis	1.82e-05	0.000212	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—IRS1—osteoporosis	1.79e-05	0.000209	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—WNT1—osteoporosis	1.79e-05	0.000209	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—osteoporosis	1.79e-05	0.000208	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTH—osteoporosis	1.77e-05	0.000207	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6R—osteoporosis	1.75e-05	0.000204	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGA—osteoporosis	1.74e-05	0.000203	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RAP1A—osteoporosis	1.74e-05	0.000203	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—osteoporosis	1.74e-05	0.000203	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CNR2—osteoporosis	1.73e-05	0.000201	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFATC1—osteoporosis	1.7e-05	0.000198	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—DKK1—osteoporosis	1.69e-05	0.000197	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.68e-05	0.000196	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—WNT1—osteoporosis	1.63e-05	0.000189	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTHLH—osteoporosis	1.62e-05	0.000189	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BMP2—osteoporosis	1.62e-05	0.000189	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGB—osteoporosis	1.59e-05	0.000185	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGA—osteoporosis	1.58e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AGER—osteoporosis	1.58e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ADCY5—osteoporosis	1.57e-05	0.000183	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ENO1—osteoporosis	1.56e-05	0.000182	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—osteoporosis	1.54e-05	0.000179	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PSMA5—osteoporosis	1.54e-05	0.000179	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PSMA2—osteoporosis	1.54e-05	0.000179	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PSMA2—osteoporosis	1.53e-05	0.000178	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PSMA5—osteoporosis	1.53e-05	0.000178	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—osteoporosis	1.51e-05	0.000176	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTHLH—osteoporosis	1.47e-05	0.000171	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BMP2—osteoporosis	1.47e-05	0.000171	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ADCY5—osteoporosis	1.45e-05	0.000169	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—osteoporosis	1.44e-05	0.000168	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGB—osteoporosis	1.44e-05	0.000168	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AGER—osteoporosis	1.43e-05	0.000166	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CALCA—osteoporosis	1.43e-05	0.000166	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ADCY5—osteoporosis	1.42e-05	0.000166	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—osteoporosis	1.41e-05	0.000164	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—osteoporosis	1.39e-05	0.000162	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PSMA2—osteoporosis	1.39e-05	0.000162	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PSMA5—osteoporosis	1.39e-05	0.000162	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IRS2—osteoporosis	1.37e-05	0.00016	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—osteoporosis	1.37e-05	0.00016	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTHFR—osteoporosis	1.33e-05	0.000155	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KL—osteoporosis	1.3e-05	0.000151	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CALCA—osteoporosis	1.29e-05	0.000151	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IRS2—osteoporosis	1.27e-05	0.000148	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP19A1—osteoporosis	1.25e-05	0.000145	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRS2—osteoporosis	1.25e-05	0.000145	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IRS1—osteoporosis	1.2e-05	0.00014	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KL—osteoporosis	1.18e-05	0.000137	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6R—osteoporosis	1.13e-05	0.000131	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IRS1—osteoporosis	1.11e-05	0.000129	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRS1—osteoporosis	1.09e-05	0.000127	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6R—osteoporosis	1.04e-05	0.000121	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6R—osteoporosis	1.02e-05	0.000119	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ADCY5—osteoporosis	1.02e-05	0.000119	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ADCY5—osteoporosis	1.02e-05	0.000118	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GPX1—osteoporosis	1.02e-05	0.000118	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SPP1—osteoporosis	9.83e-06	0.000114	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—osteoporosis	9.37e-06	0.000109	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ADCY5—osteoporosis	9.21e-06	0.000107	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SPP1—osteoporosis	8.91e-06	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IRS2—osteoporosis	8.89e-06	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LEP—osteoporosis	8.7e-06	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—osteoporosis	8.62e-06	0.0001	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1B—osteoporosis	8.57e-06	9.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—osteoporosis	8.3e-06	9.67e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IRS2—osteoporosis	8.06e-06	9.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LEP—osteoporosis	7.88e-06	9.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—osteoporosis	7.82e-06	9.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1B—osteoporosis	7.77e-06	9.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IRS1—osteoporosis	7.76e-06	9.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—osteoporosis	7.53e-06	8.77e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—POMC—osteoporosis	7.49e-06	8.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—POMC—osteoporosis	7.47e-06	8.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6R—osteoporosis	7.29e-06	8.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1—osteoporosis	7.19e-06	8.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IRS1—osteoporosis	7.03e-06	8.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—POMC—osteoporosis	6.77e-06	7.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6R—osteoporosis	6.61e-06	7.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1—osteoporosis	6.52e-06	7.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—osteoporosis	6.17e-06	7.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—osteoporosis	6.15e-06	7.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—osteoporosis	5.02e-06	5.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—osteoporosis	4.64e-06	5.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—osteoporosis	4.55e-06	5.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—osteoporosis	4.32e-06	5.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—osteoporosis	4.31e-06	5.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—osteoporosis	3.92e-06	4.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—osteoporosis	3.91e-06	4.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—osteoporosis	3.25e-06	3.78e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—osteoporosis	2.94e-06	3.43e-05	CbGpPWpGaD
